To enact section 3902.65 of the Revised Code to cap cost sharing for prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices.
- Chamber
- House
- Introduced
- May 13, 2025
- Last action
- May 14, 2025 — Referred to committee
- Session
- 136
- Momentum
- 45 · Moderate